Live Breaking News & Updates on Genomics

Stay informed with the latest breaking news from Genomics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Genomics and stay connected to the pulse of your community

Advances in Targeted Therapy, Treatment Disparities Among Cancer Conference Talks

Targeted therapy, genomics, and treatment disparities were among the topics that were presented by researchers from UCSF at the 2024 AACR conference.

San-diego , California , United-states , American , Scarlett-gomez , Denise-wolf , Salma-shariff-marco , Elad-ziv , Cancer-research , Socioeconomic-contributions-to-cancer-health-disparities , Department-of-laboratory-medicine , American-association-for-cancer-research

Dr. Sreekumar Raghavakaimal - Groundbreaking Cancer Research

Born in the verdant state of Kerala, India, Dr. Raghavakaimal's story began in a household brimming with life as one of six children.

India , Kerala , Madras , Tamil-nadu , Sreekumar-raghavakaimal , Impact-on-cancer-research , University-of-kerala , Metabolic-core-laboratory , Indian-institute-of-technology , University-of-wisconsin , National-foundation-for-cancer-research , Mayo-genomic-center-microarray-core-laboratory

Dr Brown on the Potential for Pirtobrutinib to Address Treatment Discontinuation in CLL

Jennifer R. Brown, MD, PhD, discusses how pirtobrutinib may address BTK inhibitor discontinuation in chronic lymphocytic leukemia.

Jenniferr-brown , Chronic-lymphocytic-leukemia-center , Dana-farber-cancer-institute , Harvard-medical-school , Margaret-collette-professor , Hematologic-oncology , Cll , Btk , Pirtobrutinib , Ash-annual-meeting , Genomics

5 Startup Opportunities In Genomics

In this article we delve into five particularly promising areas within genomics where startups able to innovate are quite literally likely to change the world.

Consumer-genetic , Genomics , Startups , Genetics , Biomarkers , Synthetic-biology , Nutrigenomics ,

Beam Therapeutics Shares Up 31% After Swinging to 4Q Profit

By Chris Wack Beam Therapeutics shares were up 31% to $47.02 after the company reported fourth-quarter earnings that beat analysts' expectations. The stock...

Chris-wack , Article-normal , Biotechnology-services , Healthcare-life-sciences , Genomics , Financial-performance , Earnings , Share-price-movement-disruptions , Corporate-industrial-news , Content-types , Factiva-filters

All of Us: 413,000 genomes across ancestries, ages, socioeconomics

Since its founding by the National Institutes of Health (NIH), the scientists of the All of Us Research Program have set the goal to analyze the largest diversity of the genomic population in the country and end the under-representation of its different groups. The project has expanded the vision of several pathologies, discovered thousands of new genetic variants, redefined the risk genes for common diseases, and stratified them, uncovering eight different forms in the case of type 2 diabetes (T2D). Their results create a pathway for a new age of precision medicine.

National-institutes-of-health , Us-research-program , National-institutes , Bioworld-science , All-of-us , Underrepresented-population , Polygenic-risk-scores , Type-2-diabetes , Precision-medicine , Nih , Drug-design

23andMe Is Under Fire. Its Founder Remains 'Optimistic'

23andMe’s CEO Anne Wojcicki has saved the genetics company from the brink of failure before. She sat down with WIRED to talk about where it goes from here.

Facebook-cambridge-analytica , Anne-wojcicki , Glaxosmithkline , Drug-administration , Nasdaq , Silicon-valley , Golden-state-killer , Science , Health , Genomics , Personal-genomics , 23andme

S&P 500 Futures Up in Premarket Trading; Cloudflare, Exelixis Lead

With U.S. stock markets set to open in two hours, (NET) was up 26.8% in pre-market trading, and (EXEL) was up 7.5%. (COIN), (MSTR), and (S) were all posting...

Microstrategy-inc , Exelixis-inc , Pinterest-inc , Sentinelone-inc , Expedia-group-inc , Cloudflare-inc , Coinbase-global-inc , Expedia-group , Article-normal , Biotechnology-services , Computers-consumer-electronics

23andMe shares slide more than 15% as lower services revenue hits Q3 results

Shares of 23andMe Holding Co. fell 15.8% Thursday after the DNA-testing company fiscal third-quarter sales declined 33%, weighed down by lower consumer...

Holding-co , Dow-jones-market , Preimplantation-genetic-screening , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Genomics , Financial-performance , Earnings , Sales-figures

DNA performance testing: DfE to research school impact

Government-commissioned researchers will investigate how parents testing their children’s DNA for school performance could create further disparities

Dna , Genomics , Schools , News ,

Live Breaking News & Updates on Genomics

In this article we delve into five particularly promising areas within genomics where startups able to innovate are quite literally likely to change the world. Consumer-genetic , Genomics , Startups , Genetics , Biomarkers , Synthetic-biology , Nutrigenomics ,

Government-commissioned researchers will investigate how parents testing their children’s DNA for school performance could create further disparitiesDna , Genomics , Schools , News ,

In this article we delve into five particularly promising areas within genomics where startups able to innovate are quite literally likely to change the world.

Consumer-genetic , Genomics , Startups , Genetics , Biomarkers , Synthetic-biology , Nutrigenomics ,

Government-commissioned researchers will investigate how parents testing their children’s DNA for school performance could create further disparities

Dna , Genomics , Schools , News ,